发明名称 |
INDUCTION OF IL-12 USING IMMUNOTHERAPY |
摘要 |
The present invention relates to compositions and methods that promote the induction of IL-12 in a patient. The composition includes activated allogeneic cells that are administered to a patient with a disease such as cancer. Administration of the composition skews the patient's immune response to a Th1 environment and produces detectable levels of IL-12 in the patient's plasma, without any IL-12 related toxicity. |
申请公布号 |
EP2704732(A4) |
申请公布日期 |
2015.02.25 |
申请号 |
EP20120779711 |
申请日期 |
2012.05.02 |
申请人 |
IMMUNOVATIVE THERAPIES, LTD. |
发明人 |
HAR-NOY, MICHAEL |
分类号 |
A61K38/20;A61K35/14;A61K38/17;A61K38/19;A61K38/21;A61K39/085;A61P31/00;A61P31/12;A61P37/04;C12N5/0783 |
主分类号 |
A61K38/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|